Description

Promocef Powder for Solution for Injections 1g. Vial №1

Ingredients:

Promocef powder for solution for injections 1g. Vial №1 contains Ceftriaxone, a third-generation cephalosporin antibiotic.

Dosage:

The recommended dosage of Promocef powder for solution for injections 1g. Vial №1 should be administered as directed by a healthcare professional. It is usually given intravenously or intramuscularly once or twice daily.

Indications:

Promocef powder for solution for injections 1g. Vial №1 is indicated for the treatment of various bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and septicemia.

Contraindications:

Do not use Promocef powder for solution for injections 1g. Vial №1 if you have a known allergy to cephalosporin antibiotics or any of the ingredients in the product. It should be used with caution in patients with a history of penicillin allergy.

Directions:

Administer Promocef powder for solution for injections 1g. Vial №1 exactly as prescribed by a healthcare provider. The injection should be given slowly over 2-4 minutes to minimize the risk of side effects.

Scientific Evidence:

Promocef powder for solution for injections 1g. Vial №1 has been extensively studied in clinical trials, demonstrating its efficacy in treating various bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy showed that ceftriaxone, the active ingredient in Promocef, is highly effective against a wide range of pathogens.

Additional Information:

It is important to complete the full course of treatment with Promocef powder for solution for injections 1g. Vial №1 as prescribed, even if symptoms improve before the course is finished. Failure to do so may result in the infection not being fully treated and could lead to antibiotic resistance.

Pharmacological Effects: Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to the death of the bacteria. It has a broad spectrum of activity and is effective against both gram-positive and gram-negative bacteria.

Clinical Trials: In a comparative study published in the International Journal of Infectious Diseases, ceftriaxone was found to be as effective as other cephalosporin antibiotics in the treatment of serious bacterial infections. The study concluded that ceftriaxone is a valuable option for the management of such infections.